Compare MLI & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLI | RGC |
|---|---|---|
| Founded | 1917 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 9.8B |
| IPO Year | N/A | 2021 |
| Metric | MLI | RGC |
|---|---|---|
| Price | $119.12 | $51.17 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 839.0K | 412.8K |
| Earning Date | 02-03-2026 | 10-24-2025 |
| Dividend Yield | ★ 0.83% | N/A |
| EPS Growth | ★ 29.94 | N/A |
| EPS | ★ 6.68 | N/A |
| Revenue | ★ $4,139,698,000.00 | N/A |
| Revenue This Year | $12.69 | N/A |
| Revenue Next Year | $7.94 | N/A |
| P/E Ratio | $17.95 | ★ N/A |
| Revenue Growth | ★ 15.71 | N/A |
| 52 Week Low | $66.84 | $0.09 |
| 52 Week High | $120.47 | $83.60 |
| Indicator | MLI | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 64.69 | 86.96 |
| Support Level | $114.75 | $20.70 |
| Resistance Level | $120.47 | $25.50 |
| Average True Range (ATR) | 2.19 | 4.69 |
| MACD | 0.07 | 2.31 |
| Stochastic Oscillator | 84.35 | 98.07 |
Mueller Industries Inc makes copper, brass, aluminum, and plastic products. The company reports three business segments: piping systems, industrial metals, and climate. Piping systems, earning majority of the company's revenue, produces tubes, fittings, rods, valves, and other products and operates various firms world-wide. The industrial metals segment manufactures impacts and micro-gauge, brass rod and copper bar products, and brass value-added products. The climate segment produces items used to create temperature-control goods, including valves, twisted tubes, coaxial heat exchangers, and others. Numerous systems use the aforementioned products, including HVAC, water distribution, refrigeration, and automotive.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.